申请人:Daiichi Pharmaceutical Co., Ltd.
公开号:US05432267A1
公开(公告)日:1995-07-11
A compound represented by formula (I): ##STR1## wherein R.sup.1 represents --CO--Z.sup.1 --N(Z.sup.11)--CO--Z.sup.2 --H or --CO--Z.sup.3 --H, wherein Z.sup.1, Z.sup.2, and Z.sup.3 each represent an alkylene group having from 1 to 20 carbon atoms, a phenylene group, or a combination thereof, and Z.sup.11 represents a hydrogen atom, an alkyl group having from 1 to 20 carbon atoms which may be substituted with a phenyl group, a phenyl group which may be substituted with an alkyl group having from 1 to 20 carbon atoms, or an alkylene group having from 1 to 20 carbon atoms which may contain therein a phenylene group; R.sup.2 represents --CO--Z.sup.4 --N(Z.sup.12)--CO--Z.sup.5 --H, --CO--Z.sup.6 --H or a hydrogen atom, wherein Z.sup.4, Z.sup.5, and Z.sup.6 each have the same meaning as Z.sup.1, and Z.sup.12 has the same meaning as Z.sup.11 ; Q.sup.1 and Q.sup.2 each represent a carboxyl group or a phosphonoxy group; Q.sup.3 represents a hydrogen atom, a carboxyl group or a phosphonoxy group; m represents 0 or an integer of from 1 to 20; n represents 0 or an integer of from 1 to 20; Y.sup.1 represents an alkylene group having from 1 to 10 carbon atoms which may contain one or more substituents selected from --OCOR.sup.11 and --NHCOR.sup.12, wherein R.sup.11 represents --Z.sup.13 or --Z.sup.7 --N (Z.sup.14)--CO--Z.sup.8 --H (wherein Z.sup.7 and Z.sup.8 each have the same meaning as Z.sup.1, and Z.sup.13 and Z.sup.14 each have the same meaning as Z.sup.11) and R.sup.12 represents --Z.sup.15 or --Z.sup.9 --N(Z.sup.16)--CO--Z.sup.10 --H (wherein Z.sup.9 and Z.sup.10 each have the same meaning as Z.sup.1, and Z.sup.15 and Z.sup.16 each have the same meaning as Z.sup.11), and a salt thereof. The compound inhibits TNF derivation by endotoxin and is therefore useful for the treatment of multiorganic insufficiencies.
一种由化学式(I)表示的化合物:##STR1## 其中R.sup.1代表--CO--Z.sup.1--N(Z.sup.11)--CO--Z.sup.2--H或--CO--Z.sup.3--H,其中Z.sup.1、Z.sup.2和Z.sup.3分别代表具有1至20个碳原子的烷基基团、苯基团或它们的组合,Z.sup.11代表氢原子、具有1至20个碳原子的烷基基团,可被苯基取代,可被具有1至20个碳原子的烷基基团取代的苯基团,或者具有1至20个碳原子的烷基基团,其中可能含有苯基团;R.sup.2代表--CO--Z.sup.4--N(Z.sup.12)--CO--Z.sup.5--H,--CO--Z.sup.6--H或氢原子,其中Z.sup.4、Z.sup.5和Z.sup.6的含义与Z.sup.1相同,Z.sup.12的含义与Z.sup.11相同;Q.sup.1和Q.sup.2分别代表羧基或膦氧基;Q.sup.3代表氢原子、羧基或膦氧基;m代表0或1至20的整数;n代表0或1至20的整数;Y.sup.1代表具有1至10个碳原子的烷基基团,可能含有一个或多个取代基,选自--OCOR.sup.11和--NHCOR.sup.12,其中R.sup.11代表--Z.sup.13或--Z.sup.7--N(Z.sup.14)--CO--Z.sup.8--H(其中Z.sup.7和Z.sup.8的含义与Z.sup.1相同,Z.sup.13和Z.sup.14的含义与Z.sup.11相同)和R.sup.12代表--Z.sup.15或--Z.sup.9--N(Z.sup.16)--CO--Z.sup.10--H(其中Z.sup.9和Z.sup.10的含义与Z.sup.1相同,Z.sup.15和Z.sup.16的含义与Z.sup.11相同),以及其盐。该化合物通过内毒素抑制TNF的衍生,因此对于治疗多器官功能不全是有用的。